Purchase Order 75D30122P14951

Award Date 9/15/22
Potential Completion Date 9/30/22
Potential Value $76K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Plainfield, NJ 07069, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Premier Medical USA Corp for the SURE STATUS HIV-1 RECENCY TEST (25 TESTS/KIT). The contract has a ceiling value of $50,450.00 and a period of performance through July 30, 2029. There is no set-aside designation associated with this contract. The place of performance is Somerset, Franklin Township, New Jersey.</p>
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $24,069.52 purchase order to Fujirebio US, Inc. for INNO-LIA HIV I/II SCORE tests. Fujirebio US, Inc. will deliver the tests from its division location in Chamblee, Georgia under the firm fixed price contract, which runs from July 20 through September 30, 2023. No set aside designation or subcontractors were indicated. The Centers for Disease Control and Prevention works to protect...
The Centers for Disease Control and Prevention (CDC) in Pittsburgh has awarded a $57,490.00 firm fixed-price purchase order to Seegene USA Inc. Sales Division, a foreign-owned, for-profit small disadvantaged business, for the procurement of NOVAPLEX HPV28 DETECTION KITS. The award has an ultimate completion date of May 30, 2025 and supports the CDC's public health mission related to HPV screening and prevention. This order follows previous contract awards to Seegene USA Inc. Sales Division for...
This federal contract award is for a firm fixed-price purchase order from the Centers for Disease Control and Prevention (CDC) to Sedia Biosciences Corporation, doing business as Sedia Biosciences Corp, a private medical device and diagnostics company. The $92,565.00 award is for the delivery of rapid HIV recency assay kits, laboratory reagents, and related equipment to support CDC disease surveillance and prevention initiatives in the United States. Sedia Biosciences Corp has previously been...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The $91,758.84 firm fixed-price purchase order is for the delivery of HIV test kits and supplies. The contract does not have a set-aside designation and has an ultimate completion date of December 31, 2021. Life Technologies Corporation, as the prime contractor, is a leading provider of biomedical research and genetic...
This is a federal purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to LGC Clinical Diagnostics Inc., a foreign-owned for-profit manufacturer of clinical diagnostic products. The contract, valued at $21,556.49, is for the provision of HIV Performance Panels, which are quality control tools used in clinical laboratories. The contract has a completion date of September 30, 2019 and a firm fixed price pricing type. This...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh has awarded a $85,500 firm fixed price purchase order to Seegene USA Inc. Sales Division, a foreign-owned, small disadvantaged business, for the delivery of an HPV Detection RUO Assay. This purchase order will provide the CDC Pittsburgh location with HPV test kits, reagents, and Novaplex II HPV28 detection kits to support the agency's public health mission related to HPV screening and prevention....
The Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Sedia Biosciences Corporation, a privately held medical device and diagnostics company, to provide Asante HIV-1 Rapid Recency Assays and HIV-1 LAg-Avidity EIA Avidity Kits. The $119,155.00 contract was awarded on September 3, 2020, with a completion date of April 15, 2021. These products are used in the CDC's ongoing HIV surveillance program and are only available from Sedia Biosciences Corporation....
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Maxim Biomedical, Inc., a small disadvantaged, woman-owned, Asian-Pacific American-owned medical device manufacturing company based in Rockville, Maryland. The $120,150.00 award is for the provision of SWIFT HIV RECENT INFECTION ASSAY (RIA) KITS. This sole source contract was issued under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1) due to brand name...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) has awarded a $1,842,580.00 firm-fixed-price definitive contract to Premier Healthcare Solutions, Inc., doing business as Premier Healthcare Alliance, for comprehensive and longitudinal inpatient and hospital-based outpatient healthcare data extracts. This contract, which does not have a set-aside designation, will support the CDC's COVID-19 response, post-COVID activities, and other public health...

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $75,680 firm fixed price purchase order to Premier Medical USA Corporation of Plainfield, NJ for the delivery of SURESTATUS HIV-1 RECENCY CARD TEST AND FIRST RESPONSE HIV 1-2.O CARD TEST (VERSION 2.0). The tests will help the CDC monitor and track HIV infection rates as part of its efforts to prevent and treat HIV/AIDS. No set-aside designation was used for this award. Premier Medical USA Corporation, a for-profit, Subcontinent Asian American-owned business, will serve as the prime contractor to fulfill the agency's requirements for these HIV diagnostic tests by the completion date of September 30, 2022.

Generated 2/1/24, 10:08 AM